Extracellular-regulated-kinase 5-mediated renal protection against ischemia–reperfusion injury

ERK5, a member of the mitogen activated protein kinase, expressed in the kidneys was smaller (∼80 kDa) in apparent molecular mass compared to other organs (∼120 kDa). A blocking peptide experiment confirmed that the ∼80 kDa detected on Western blots was a specific band detected by the anti-ERK5 antibody. Expression of the known ERK5 variants ERK5a, b, c, and T confirmed that none of the known splice variants encoded for the renal-specific ∼80 kDa protein. However, RT-PCR with primers targeting the potential splice sites did not reveal a novel transcript in the kidney. The smaller molecular mass of the kidney-specific ERK5-immunoreactive protein suggested that this cyto-protective molecule may not be fully functional in the kidneys. Lentivirus-mediated in vivo overexpression of full length ERK5 in the mouse kidneys provided protection against renal IR injury. The identity of the renal-specific ∼80 kDa ERK5 remains unknown but a better understanding of the ERK5 expression and post-translational processing in the kidneys may reveal a novel strategy for renal protection.

► ERK5 in the kidney has a smaller apparent molecular mass. ► This is distinct from all known ERK5 variants. ► Rt-PCR failed to detect novel ERK5 transcripts in the kidney. ► Lentivirus-mediated expression of full-length ERK5 protects against IR injury.